🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase 2 open-label trial designed to evaluate the efficacy of til...
Status
Completed
Location
Froedtert Hospital and the Medical College of Wisconsin
Start Date
2020-03-01
Trial ID
NCT04112810
Treatments Being Tested
Design: Single-center open-label clinical trial. Objective: Evaluate if ti...
Status
Completed
Location
Clinical Trials Center for Skin Diseases: Rhode Island Hospital, 593 Eddy Street, Dermatology Research, Jane Brown Building, 1st floor, Room 115
Start Date
2022-04-08
Trial ID
NCT05110313
Treatments Being Tested
This study is being conducted to evaluate the efficacy and safety/tolerabil...
Status
Completed
Location
Multiple Locations
Start Date
2013-02-05
Trial ID
NCT01729754
Psoriasis, a common chronic inflammatory skin disease affecting approximate...
Status
Completed
Location
Brigham and Women's Hospital
Start Date
2020-04-04
Trial ID
NCT04271540
Treatments Being Tested
Vitiligo is a common acquired depigmentation disorder affecting approximate...
Status
Completed
Location
Premier Specialists Pty Ltd
Start Date
2021-09-16
Trial ID
NCT04971200
Treatments Being Tested
This study will utilize a prospective, observational, exposure cohort desig...
Status
Recruiting
Location
Christina Chambers
Start Date
2019-08-29
Trial ID
NCT03992729
Treatments Being Tested
The main objective of this study is to investigate whether controlled dose ...
Status
Completed
Location
ULB Erasme
Start Date
2020-08-20
Trial ID
NCT04340076
Treatments Being Tested
The main aim of the study is to evaluate the efficacy, safety and impact on...
Status
Completed
Location
Investigator Site 9
Start Date
2019-12-17
Trial ID
NCT04229836
Treatments Being Tested
This is an open-label, pilot study evaluating the efficacy of tildrakizumab...
Status
Unknown
Location
Multiple Locations
Start Date
2020-09-01
Trial ID
NCT04465292
Treatments Being Tested
This is a multicenter Phase III, Randomized, Double-Blind, Single-Dose, Pla...
Status
Completed
Location
Sunpharma Site no 42
Start Date
2020-07-01
Trial ID
NCT04314544
Treatments Being Tested